nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—hematologic cancer	0.149	0.583	CbGaD
Testosterone Propionate—breast cancer—Dexamethasone—hematologic cancer	0.131	0.5	CpDpCtD
Testosterone Propionate—breast cancer—Betamethasone—hematologic cancer	0.131	0.5	CpDpCtD
Testosterone Propionate—AR—hematologic cancer	0.106	0.417	CbGaD
Testosterone Propionate—CYP17A1—Dexamethasone—hematologic cancer	0.0363	0.328	CbGbCtD
Testosterone Propionate—UGT1A1—Nilotinib—hematologic cancer	0.0333	0.301	CbGbCtD
Testosterone Propionate—UGT1A1—Irinotecan—hematologic cancer	0.0229	0.207	CbGbCtD
Testosterone Propionate—UGT1A1—Etoposide—hematologic cancer	0.0183	0.165	CbGbCtD
Testosterone Propionate—CYP17A1—ovarian follicle—hematologic cancer	0.0114	0.488	CbGeAlD
Testosterone Propionate—Potassium Canrenoate—Prednisone—hematologic cancer	0.00915	0.0419	CrCrCtD
Testosterone Propionate—Potassium Canrenoate—Prednisolone—hematologic cancer	0.00893	0.0409	CrCrCtD
Testosterone Propionate—Danazol—Prednisone—hematologic cancer	0.00772	0.0354	CrCrCtD
Testosterone Propionate—Medrysone—Prednisolone—hematologic cancer	0.00754	0.0345	CrCrCtD
Testosterone Propionate—Testolactone—Betamethasone—hematologic cancer	0.00681	0.0312	CrCrCtD
Testosterone Propionate—Testolactone—Dexamethasone—hematologic cancer	0.00681	0.0312	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisone—hematologic cancer	0.00672	0.0308	CrCrCtD
Testosterone Propionate—Testolactone—Triamcinolone—hematologic cancer	0.00666	0.0305	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisolone—hematologic cancer	0.00656	0.03	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisone—hematologic cancer	0.00651	0.0298	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisolone—hematologic cancer	0.00635	0.0291	CrCrCtD
Testosterone Propionate—Testolactone—Prednisone—hematologic cancer	0.00632	0.0289	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Betamethasone—hematologic cancer	0.00626	0.0287	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00626	0.0287	CrCrCtD
Testosterone Propionate—Testolactone—Prednisolone—hematologic cancer	0.00617	0.0282	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00612	0.028	CrCrCtD
Testosterone Propionate—Fludrocortisone—Betamethasone—hematologic cancer	0.0061	0.0279	CrCrCtD
Testosterone Propionate—Fludrocortisone—Dexamethasone—hematologic cancer	0.0061	0.0279	CrCrCtD
Testosterone Propionate—Fludrocortisone—Triamcinolone—hematologic cancer	0.00596	0.0273	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Prednisolone—hematologic cancer	0.00567	0.026	CrCrCtD
Testosterone Propionate—Loteprednol—Dexamethasone—hematologic cancer	0.00566	0.026	CrCrCtD
Testosterone Propionate—Loteprednol—Betamethasone—hematologic cancer	0.00566	0.026	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisone—hematologic cancer	0.00566	0.0259	CrCrCtD
Testosterone Propionate—Loteprednol—Triamcinolone—hematologic cancer	0.00553	0.0254	CrCrCtD
Testosterone Propionate—Progesterone—Prednisolone—hematologic cancer	0.00552	0.0253	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisolone—hematologic cancer	0.00552	0.0253	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisone—hematologic cancer	0.00551	0.0253	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisolone—hematologic cancer	0.00538	0.0247	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisone—hematologic cancer	0.00525	0.0241	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisolone—hematologic cancer	0.00513	0.0235	CrCrCtD
Testosterone Propionate—Hydrocortisone—Betamethasone—hematologic cancer	0.00497	0.0228	CrCrCtD
Testosterone Propionate—Hydrocortisone—Dexamethasone—hematologic cancer	0.00497	0.0228	CrCrCtD
Testosterone Propionate—Hydrocortisone—Triamcinolone—hematologic cancer	0.00486	0.0223	CrCrCtD
Testosterone Propionate—Testosterone—Prednisolone—hematologic cancer	0.00479	0.022	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisone—hematologic cancer	0.00461	0.0211	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisolone—hematologic cancer	0.0045	0.0206	CrCrCtD
Testosterone Propionate—UGT1A1—hematopoietic system—hematologic cancer	0.00126	0.0539	CbGeAlD
Testosterone Propionate—CYP17A1—gonad—hematologic cancer	0.00105	0.0448	CbGeAlD
Testosterone Propionate—COMT—hematopoietic system—hematologic cancer	0.00101	0.0431	CbGeAlD
Testosterone Propionate—UGT1A1—blood—hematologic cancer	0.000833	0.0357	CbGeAlD
Testosterone Propionate—COMT—gonad—hematologic cancer	0.000765	0.0327	CbGeAlD
Testosterone Propionate—CYP17A1—testis—hematologic cancer	0.000754	0.0323	CbGeAlD
Testosterone Propionate—AR—hematopoietic system—hematologic cancer	0.000736	0.0315	CbGeAlD
Testosterone Propionate—COMT—blood—hematologic cancer	0.000666	0.0285	CbGeAlD
Testosterone Propionate—COMT—bone marrow—hematologic cancer	0.000645	0.0276	CbGeAlD
Testosterone Propionate—COMT—lung—hematologic cancer	0.000584	0.025	CbGeAlD
Testosterone Propionate—AR—gonad—hematologic cancer	0.00056	0.024	CbGeAlD
Testosterone Propionate—COMT—testis—hematologic cancer	0.000551	0.0236	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—hematologic cancer	0.000546	0.0234	CbGeAlD
Testosterone Propionate—AR—blood—hematologic cancer	0.000488	0.0209	CbGeAlD
Testosterone Propionate—AR—lung—hematologic cancer	0.000427	0.0183	CbGeAlD
Testosterone Propionate—AR—testis—hematologic cancer	0.000403	0.0173	CbGeAlD
Testosterone Propionate—COMT—lymph node—hematologic cancer	0.000399	0.0171	CbGeAlD
Testosterone Propionate—AR—lymph node—hematologic cancer	0.000292	0.0125	CbGeAlD
Testosterone Propionate—Stanozolol—AR—hematologic cancer	0.000166	0.0714	CrCbGaD
Testosterone Propionate—Oxandrolone—AR—hematologic cancer	0.00015	0.0643	CrCbGaD
Testosterone Propionate—Nandrolone phenpropionate—AR—hematologic cancer	0.000117	0.0503	CrCbGaD
Testosterone Propionate—Danazol—CCL2—hematologic cancer	0.000108	0.0463	CrCbGaD
Testosterone Propionate—Drostanolone—AR—hematologic cancer	9.96e-05	0.0428	CrCbGaD
Testosterone Propionate—Nandrolone decanoate—AR—hematologic cancer	8.88e-05	0.0381	CrCbGaD
Testosterone Propionate—Ethynodiol—ESR1—hematologic cancer	8.74e-05	0.0375	CrCbGaD
Testosterone Propionate—Norgestimate—ESR1—hematologic cancer	7.43e-05	0.0319	CrCbGaD
Testosterone Propionate—Drospirenone—AR—hematologic cancer	7.24e-05	0.0311	CrCbGaD
Testosterone Propionate—Loteprednol—NR3C1—hematologic cancer	6.91e-05	0.0297	CrCbGaD
Testosterone Propionate—Fludrocortisone—AR—hematologic cancer	6.81e-05	0.0293	CrCbGaD
Testosterone Propionate—Medrysone—NR3C1—hematologic cancer	6.35e-05	0.0273	CrCbGaD
Testosterone Propionate—Hydrocortamate—NR3C1—hematologic cancer	5.92e-05	0.0254	CrCbGaD
Testosterone Propionate—Levonorgestrel—AR—hematologic cancer	5.9e-05	0.0254	CrCbGaD
Testosterone Propionate—Cortisone acetate—NR3C1—hematologic cancer	5.83e-05	0.025	CrCbGaD
Testosterone Propionate—Fluoxymesterone—AR—hematologic cancer	5.63e-05	0.0242	CrCbGaD
Testosterone Propionate—Megestrol acetate—NR3C1—hematologic cancer	5.62e-05	0.0241	CrCbGaD
Testosterone Propionate—Danazol—AR—hematologic cancer	5.38e-05	0.0231	CrCbGaD
Testosterone Propionate—Spironolactone—AR—hematologic cancer	5.15e-05	0.0221	CrCbGaD
Testosterone Propionate—Medroxyprogesterone Acetate—AR—hematologic cancer	4.83e-05	0.0207	CrCbGaD
Testosterone Propionate—Fludrocortisone—NR3C1—hematologic cancer	4.62e-05	0.0198	CrCbGaD
Testosterone Propionate—Levonorgestrel—ESR1—hematologic cancer	4.55e-05	0.0195	CrCbGaD
Testosterone Propionate—Methyltestosterone—AR—hematologic cancer	4.54e-05	0.0195	CrCbGaD
Testosterone Propionate—Fluoxymesterone—ESR1—hematologic cancer	4.33e-05	0.0186	CrCbGaD
Testosterone Propionate—Danazol—ESR1—hematologic cancer	4.14e-05	0.0178	CrCbGaD
Testosterone Propionate—Fluoxymesterone—NR3C1—hematologic cancer	3.82e-05	0.0164	CrCbGaD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—hematologic cancer	3.72e-05	0.016	CrCbGaD
Testosterone Propionate—Spironolactone—NR3C1—hematologic cancer	3.49e-05	0.015	CrCbGaD
Testosterone Propionate—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	3.27e-05	0.0141	CrCbGaD
Testosterone Propionate—Progesterone—SLC22A1—hematologic cancer	3.14e-05	0.0135	CrCbGaD
Testosterone Propionate—Testosterone—SLC22A1—hematologic cancer	2.97e-05	0.0127	CrCbGaD
Testosterone Propionate—Progesterone—AR—hematologic cancer	2.79e-05	0.012	CrCbGaD
Testosterone Propionate—Megestrol acetate—ABCB1—hematologic cancer	2.71e-05	0.0116	CrCbGaD
Testosterone Propionate—Hydrocortisone—ABCG2—hematologic cancer	2.69e-05	0.0116	CrCbGaD
Testosterone Propionate—Testosterone—AR—hematologic cancer	2.64e-05	0.0113	CrCbGaD
Testosterone Propionate—Hydrocortisone—NR3C1—hematologic cancer	2.32e-05	0.00997	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.27e-05	0.000712	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.27e-05	0.000712	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—BRAF—hematologic cancer	2.26e-05	0.00071	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTAP—hematologic cancer	2.24e-05	0.000705	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RARS—hematologic cancer	2.22e-05	0.000698	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SMPD3—hematologic cancer	2.18e-05	0.000684	CbGpPWpGaD
Testosterone Propionate—Progesterone—ESR1—hematologic cancer	2.15e-05	0.00922	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	2.12e-05	0.000665	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.09e-05	0.000656	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—POLR3E—hematologic cancer	2.09e-05	0.000656	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—FHL2—hematologic cancer	2.09e-05	0.000656	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—hematologic cancer	2.09e-05	0.000655	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	2.09e-05	0.000655	CbGpPWpGaD
Testosterone Propionate—Testosterone—ABCG2—hematologic cancer	2.07e-05	0.0089	CrCbGaD
Testosterone Propionate—COMT—Metabolism—AGRN—hematologic cancer	2.05e-05	0.000643	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.04e-05	0.000642	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.03e-05	0.000639	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	2.03e-05	0.000637	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PARP1—hematologic cancer	2.01e-05	0.000631	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—FHL2—hematologic cancer	2e-05	0.000628	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AGRN—hematologic cancer	1.96e-05	0.000616	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.94e-05	0.00061	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—IDH2—hematologic cancer	1.94e-05	0.00061	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HMMR—hematologic cancer	1.94e-05	0.00061	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DCK—hematologic cancer	1.9e-05	0.000598	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ASNS—hematologic cancer	1.9e-05	0.000598	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—B3GAT1—hematologic cancer	1.9e-05	0.000598	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MDM2—hematologic cancer	1.89e-05	0.000594	CbGpPWpGaD
Testosterone Propionate—Progesterone—NR3C1—hematologic cancer	1.89e-05	0.00812	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	1.87e-05	0.000586	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—IDH2—hematologic cancer	1.86e-05	0.000584	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMMR—hematologic cancer	1.86e-05	0.000584	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.85e-05	0.00058	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ARNTL—hematologic cancer	1.82e-05	0.000573	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.82e-05	0.000572	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.82e-05	0.000571	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	1.82e-05	0.000571	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—JUN—hematologic cancer	1.81e-05	0.000569	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TET2—hematologic cancer	1.81e-05	0.000569	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RARA—hematologic cancer	1.81e-05	0.000569	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HDC—hematologic cancer	1.8e-05	0.000567	CbGpPWpGaD
Testosterone Propionate—Asthenia—Cisplatin—hematologic cancer	1.79e-05	0.000187	CcSEcCtD
Testosterone Propionate—Fatigue—Triamcinolone—hematologic cancer	1.78e-05	0.000186	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Epirubicin—hematologic cancer	1.78e-05	0.000186	CcSEcCtD
Testosterone Propionate—Rash—Vincristine—hematologic cancer	1.78e-05	0.000186	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—RPLP1—hematologic cancer	1.78e-05	0.000558	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ACP5—hematologic cancer	1.77e-05	0.000558	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CA9—hematologic cancer	1.77e-05	0.000558	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Vincristine—hematologic cancer	1.77e-05	0.000185	CcSEcCtD
Testosterone Propionate—Pain—Triamcinolone—hematologic cancer	1.77e-05	0.000185	CcSEcCtD
Testosterone Propionate—Haematuria—Doxorubicin—hematologic cancer	1.77e-05	0.000185	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—hematologic cancer	1.77e-05	0.000185	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.77e-05	0.000555	CbGpPWpGaD
Testosterone Propionate—Urethral disorder—Epirubicin—hematologic cancer	1.76e-05	0.000184	CcSEcCtD
Testosterone Propionate—Headache—Vincristine—hematologic cancer	1.76e-05	0.000184	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.75e-05	0.000183	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.75e-05	0.000551	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	1.75e-05	0.000551	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.75e-05	0.00055	CbGpPWpGaD
Testosterone Propionate—Nausea—Carmustine—hematologic cancer	1.75e-05	0.000183	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NCOR2—hematologic cancer	1.75e-05	0.00055	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ARNTL—hematologic cancer	1.75e-05	0.000549	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Methotrexate—hematologic cancer	1.74e-05	0.000182	CcSEcCtD
Testosterone Propionate—Vomiting—Mitoxantrone—hematologic cancer	1.74e-05	0.000182	CcSEcCtD
Testosterone Propionate—Vomiting—Irinotecan—hematologic cancer	1.74e-05	0.000182	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methotrexate—hematologic cancer	1.74e-05	0.000182	CcSEcCtD
Testosterone Propionate—Nausea—Alitretinoin—hematologic cancer	1.74e-05	0.000181	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methotrexate—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—Hypertension—Prednisone—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—Rash—Irinotecan—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—Rash—Mitoxantrone—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.73e-05	0.000543	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Irinotecan—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—Dermatitis—Mitoxantrone—hematologic cancer	1.73e-05	0.000181	CcSEcCtD
Testosterone Propionate—Headache—Mitoxantrone—hematologic cancer	1.72e-05	0.00018	CcSEcCtD
Testosterone Propionate—Headache—Irinotecan—hematologic cancer	1.72e-05	0.00018	CcSEcCtD
Testosterone Propionate—Nausea—Ifosfamide—hematologic cancer	1.72e-05	0.000179	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.71e-05	0.000179	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.71e-05	0.000179	CcSEcCtD
Testosterone Propionate—Arthralgia—Prednisone—hematologic cancer	1.71e-05	0.000178	CcSEcCtD
Testosterone Propionate—Myalgia—Prednisone—hematologic cancer	1.71e-05	0.000178	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Triamcinolone—hematologic cancer	1.7e-05	0.000178	CcSEcCtD
Testosterone Propionate—Diarrhoea—Cisplatin—hematologic cancer	1.7e-05	0.000178	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CA9—hematologic cancer	1.7e-05	0.000534	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ACP5—hematologic cancer	1.7e-05	0.000534	CbGpPWpGaD
Testosterone Propionate—Anxiety—Prednisone—hematologic cancer	1.7e-05	0.000178	CcSEcCtD
Testosterone Propionate—Alopecia—Methotrexate—hematologic cancer	1.7e-05	0.000178	CcSEcCtD
Testosterone Propionate—Vomiting—Gemcitabine—hematologic cancer	1.7e-05	0.000177	CcSEcCtD
Testosterone Propionate—Insomnia—Betamethasone—hematologic cancer	1.7e-05	0.000177	CcSEcCtD
Testosterone Propionate—Insomnia—Dexamethasone—hematologic cancer	1.7e-05	0.000177	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.69e-05	0.000177	CcSEcCtD
Testosterone Propionate—Spironolactone—ABCB1—hematologic cancer	1.69e-05	0.00724	CrCbGaD
Testosterone Propionate—Paraesthesia—Betamethasone—hematologic cancer	1.69e-05	0.000176	CcSEcCtD
Testosterone Propionate—Paraesthesia—Dexamethasone—hematologic cancer	1.69e-05	0.000176	CcSEcCtD
Testosterone Propionate—Discomfort—Prednisone—hematologic cancer	1.68e-05	0.000176	CcSEcCtD
Testosterone Propionate—Mental disorder—Methotrexate—hematologic cancer	1.68e-05	0.000176	CcSEcCtD
Testosterone Propionate—Rash—Gemcitabine—hematologic cancer	1.68e-05	0.000176	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—NR0B2—hematologic cancer	1.68e-05	0.000529	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Gemcitabine—hematologic cancer	1.68e-05	0.000176	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Etoposide—hematologic cancer	1.68e-05	0.000176	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NCOR2—hematologic cancer	1.68e-05	0.000527	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Methotrexate—hematologic cancer	1.67e-05	0.000175	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—hematologic cancer	1.67e-05	0.000175	CcSEcCtD
Testosterone Propionate—Headache—Gemcitabine—hematologic cancer	1.67e-05	0.000175	CcSEcCtD
Testosterone Propionate—Nausea—Vincristine—hematologic cancer	1.67e-05	0.000175	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EP300—hematologic cancer	1.67e-05	0.000525	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—IDH1—hematologic cancer	1.67e-05	0.000524	CbGpPWpGaD
Testosterone Propionate—Haemorrhage—Doxorubicin—hematologic cancer	1.66e-05	0.000174	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.66e-05	0.000522	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Prednisolone—hematologic cancer	1.66e-05	0.000173	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ABCC3—hematologic cancer	1.65e-05	0.000518	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTO1—hematologic cancer	1.65e-05	0.000518	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TXN—hematologic cancer	1.65e-05	0.000518	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CDA—hematologic cancer	1.65e-05	0.000518	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—hematologic cancer	1.64e-05	0.000172	CcSEcCtD
Testosterone Propionate—Urticaria—Triamcinolone—hematologic cancer	1.64e-05	0.000172	CcSEcCtD
Testosterone Propionate—Norethindrone—ALB—hematologic cancer	1.64e-05	0.00705	CrCbGaD
Testosterone Propionate—Asthenia—Etoposide—hematologic cancer	1.64e-05	0.000171	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—hematologic cancer	1.64e-05	0.000171	CcSEcCtD
Testosterone Propionate—Oedema—Prednisone—hematologic cancer	1.63e-05	0.000171	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Prednisone—hematologic cancer	1.63e-05	0.000171	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—hematologic cancer	1.63e-05	0.000171	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—hematologic cancer	1.63e-05	0.000171	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.63e-05	0.000512	CbGpPWpGaD
Testosterone Propionate—Nausea—Irinotecan—hematologic cancer	1.63e-05	0.00017	CcSEcCtD
Testosterone Propionate—Nausea—Mitoxantrone—hematologic cancer	1.63e-05	0.00017	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—hematologic cancer	1.63e-05	0.00017	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—hematologic cancer	1.62e-05	0.00017	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.62e-05	0.000169	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.62e-05	0.000169	CcSEcCtD
Testosterone Propionate—Fatigue—Dexamethasone—hematologic cancer	1.62e-05	0.000169	CcSEcCtD
Testosterone Propionate—Fatigue—Betamethasone—hematologic cancer	1.62e-05	0.000169	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—SPHK1—hematologic cancer	1.61e-05	0.000507	CbGpPWpGaD
Testosterone Propionate—Pruritus—Etoposide—hematologic cancer	1.61e-05	0.000169	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—DNMT3A—hematologic cancer	1.61e-05	0.000504	CbGpPWpGaD
Testosterone Propionate—Pain—Betamethasone—hematologic cancer	1.61e-05	0.000168	CcSEcCtD
Testosterone Propionate—Pain—Dexamethasone—hematologic cancer	1.61e-05	0.000168	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Prednisone—hematologic cancer	1.6e-05	0.000168	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—IDH1—hematologic cancer	1.6e-05	0.000502	CbGpPWpGaD
Testosterone Propionate—Alopecia—Epirubicin—hematologic cancer	1.59e-05	0.000166	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—PC—hematologic cancer	1.59e-05	0.000499	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Prednisone—hematologic cancer	1.59e-05	0.000166	CcSEcCtD
Testosterone Propionate—Nausea—Gemcitabine—hematologic cancer	1.59e-05	0.000166	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	1.58e-05	0.000497	CbGpPWpGaD
Testosterone Propionate—Vomiting—Cisplatin—hematologic cancer	1.58e-05	0.000165	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—ELL—hematologic cancer	1.58e-05	0.000497	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCC3—hematologic cancer	1.58e-05	0.000496	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TXN—hematologic cancer	1.58e-05	0.000496	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTO1—hematologic cancer	1.58e-05	0.000496	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.58e-05	0.000496	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Epirubicin—hematologic cancer	1.58e-05	0.000165	CcSEcCtD
Testosterone Propionate—Rash—Cisplatin—hematologic cancer	1.57e-05	0.000164	CcSEcCtD
Testosterone Propionate—Dermatitis—Cisplatin—hematologic cancer	1.57e-05	0.000164	CcSEcCtD
Testosterone Propionate—Malnutrition—Epirubicin—hematologic cancer	1.57e-05	0.000164	CcSEcCtD
Testosterone Propionate—Norethindrone—ABCB1—hematologic cancer	1.57e-05	0.00673	CrCbGaD
Testosterone Propionate—Diarrhoea—Etoposide—hematologic cancer	1.56e-05	0.000163	CcSEcCtD
Testosterone Propionate—Methyltestosterone—ALB—hematologic cancer	1.56e-05	0.00669	CrCbGaD
Testosterone Propionate—Ill-defined disorder—Methotrexate—hematologic cancer	1.55e-05	0.000162	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—UGT1A1—hematologic cancer	1.55e-05	0.000487	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.55e-05	0.000486	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Dexamethasone—hematologic cancer	1.55e-05	0.000162	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Betamethasone—hematologic cancer	1.55e-05	0.000162	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SPHK1—hematologic cancer	1.55e-05	0.000486	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.55e-05	0.000486	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.54e-05	0.000485	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—hematologic cancer	1.54e-05	0.000484	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.53e-05	0.00016	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Betamethasone—hematologic cancer	1.53e-05	0.00016	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SLC35B2—hematologic cancer	1.53e-05	0.000482	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GBA—hematologic cancer	1.53e-05	0.000482	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Triamcinolone—hematologic cancer	1.52e-05	0.000159	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—NCOR2—hematologic cancer	1.52e-05	0.000477	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—hematologic cancer	1.51e-05	0.000158	CcSEcCtD
Testosterone Propionate—Malaise—Methotrexate—hematologic cancer	1.51e-05	0.000158	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CRABP1—hematologic cancer	1.51e-05	0.000474	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC22A1—hematologic cancer	1.51e-05	0.000474	CbGpPWpGaD
Testosterone Propionate—Dizziness—Etoposide—hematologic cancer	1.51e-05	0.000158	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.51e-05	0.000473	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Doxorubicin—hematologic cancer	1.5e-05	0.000157	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.5e-05	0.000472	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—hematologic cancer	1.5e-05	0.000157	CcSEcCtD
Testosterone Propionate—Urticaria—Dexamethasone—hematologic cancer	1.49e-05	0.000156	CcSEcCtD
Testosterone Propionate—Urticaria—Betamethasone—hematologic cancer	1.49e-05	0.000156	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.49e-05	0.000156	CcSEcCtD
Testosterone Propionate—Dizziness—Prednisolone—hematologic cancer	1.49e-05	0.000155	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—UGT1A1—hematologic cancer	1.49e-05	0.000467	CbGpPWpGaD
Testosterone Propionate—Asthenia—Triamcinolone—hematologic cancer	1.48e-05	0.000155	CcSEcCtD
Testosterone Propionate—Abdominal pain—Dexamethasone—hematologic cancer	1.48e-05	0.000155	CcSEcCtD
Testosterone Propionate—Abdominal pain—Betamethasone—hematologic cancer	1.48e-05	0.000155	CcSEcCtD
Testosterone Propionate—Nausea—Cisplatin—hematologic cancer	1.48e-05	0.000155	CcSEcCtD
Testosterone Propionate—Insomnia—Prednisone—hematologic cancer	1.48e-05	0.000155	CcSEcCtD
Testosterone Propionate—Alopecia—Doxorubicin—hematologic cancer	1.47e-05	0.000154	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ALOX5—hematologic cancer	1.47e-05	0.000462	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NCOR1—hematologic cancer	1.47e-05	0.000461	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Prednisone—hematologic cancer	1.47e-05	0.000153	CcSEcCtD
Testosterone Propionate—Pruritus—Triamcinolone—hematologic cancer	1.46e-05	0.000153	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—hematologic cancer	1.46e-05	0.000152	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—hematologic cancer	1.46e-05	0.000458	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.46e-05	0.000457	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Epirubicin—hematologic cancer	1.45e-05	0.000152	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.45e-05	0.000456	CbGpPWpGaD
Testosterone Propionate—Vomiting—Etoposide—hematologic cancer	1.45e-05	0.000152	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—hematologic cancer	1.45e-05	0.000151	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SLC22A1—hematologic cancer	1.45e-05	0.000454	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CRABP1—hematologic cancer	1.45e-05	0.000454	CbGpPWpGaD
Testosterone Propionate—Rash—Etoposide—hematologic cancer	1.44e-05	0.00015	CcSEcCtD
Testosterone Propionate—Dermatitis—Etoposide—hematologic cancer	1.44e-05	0.00015	CcSEcCtD
Testosterone Propionate—Headache—Etoposide—hematologic cancer	1.43e-05	0.000149	CcSEcCtD
Testosterone Propionate—Arthralgia—Methotrexate—hematologic cancer	1.43e-05	0.000149	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—hematologic cancer	1.43e-05	0.000149	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NUP98—hematologic cancer	1.42e-05	0.000447	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.42e-05	0.000446	CbGpPWpGaD
Testosterone Propionate—Rash—Prednisolone—hematologic cancer	1.42e-05	0.000148	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisolone—hematologic cancer	1.42e-05	0.000148	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.42e-05	0.000148	CcSEcCtD
Testosterone Propionate—Malaise—Epirubicin—hematologic cancer	1.41e-05	0.000148	CcSEcCtD
Testosterone Propionate—Fatigue—Prednisone—hematologic cancer	1.41e-05	0.000147	CcSEcCtD
Testosterone Propionate—Headache—Prednisolone—hematologic cancer	1.41e-05	0.000147	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ALOX5—hematologic cancer	1.41e-05	0.000442	CbGpPWpGaD
Testosterone Propionate—Discomfort—Methotrexate—hematologic cancer	1.41e-05	0.000147	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—MTAP—hematologic cancer	1.4e-05	0.000441	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AGO2—hematologic cancer	1.4e-05	0.00044	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.39e-05	0.000435	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ADCY7—hematologic cancer	1.38e-05	0.000434	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NCOA3—hematologic cancer	1.38e-05	0.000434	CbGpPWpGaD
Testosterone Propionate—Confusional state—Methotrexate—hematologic cancer	1.38e-05	0.000144	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NUP214—hematologic cancer	1.37e-05	0.000431	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—H3F3B—hematologic cancer	1.37e-05	0.000431	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—DNMT3B—hematologic cancer	1.37e-05	0.000431	CbGpPWpGaD
Testosterone Propionate—Dizziness—Triamcinolone—hematologic cancer	1.37e-05	0.000143	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Methotrexate—hematologic cancer	1.37e-05	0.000143	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NUP98—hematologic cancer	1.36e-05	0.000428	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NR3C1—hematologic cancer	1.36e-05	0.000427	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.36e-05	0.000426	CbGpPWpGaD
Testosterone Propionate—Nausea—Etoposide—hematologic cancer	1.35e-05	0.000142	CcSEcCtD
Testosterone Propionate—Hypertension—Epirubicin—hematologic cancer	1.35e-05	0.000141	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.35e-05	0.000423	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Prednisone—hematologic cancer	1.35e-05	0.000141	CcSEcCtD
Testosterone Propionate—Asthenia—Betamethasone—hematologic cancer	1.35e-05	0.000141	CcSEcCtD
Testosterone Propionate—Asthenia—Dexamethasone—hematologic cancer	1.35e-05	0.000141	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	1.35e-05	0.000423	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTR—hematologic cancer	1.35e-05	0.000423	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCG2—hematologic cancer	1.35e-05	0.000423	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—hematologic cancer	1.34e-05	0.000141	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methotrexate—hematologic cancer	1.34e-05	0.00014	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Prednisone—hematologic cancer	1.34e-05	0.00014	CcSEcCtD
Testosterone Propionate—Nausea—Prednisolone—hematologic cancer	1.34e-05	0.00014	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—Pruritus—Betamethasone—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—Pruritus—Dexamethasone—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—Skin disorder—Methotrexate—hematologic cancer	1.33e-05	0.000139	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—hematologic cancer	1.33e-05	0.000417	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.32e-05	0.000138	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ADCY7—hematologic cancer	1.32e-05	0.000416	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NCOA3—hematologic cancer	1.32e-05	0.000416	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.32e-05	0.000415	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ENO2—hematologic cancer	1.32e-05	0.000414	CbGpPWpGaD
Testosterone Propionate—Discomfort—Epirubicin—hematologic cancer	1.32e-05	0.000138	CcSEcCtD
Testosterone Propionate—Vomiting—Triamcinolone—hematologic cancer	1.32e-05	0.000137	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NUP214—hematologic cancer	1.31e-05	0.000413	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.31e-05	0.000412	CbGpPWpGaD
Testosterone Propionate—Malaise—Doxorubicin—hematologic cancer	1.31e-05	0.000137	CcSEcCtD
Testosterone Propionate—Rash—Triamcinolone—hematologic cancer	1.3e-05	0.000136	CcSEcCtD
Testosterone Propionate—Dermatitis—Triamcinolone—hematologic cancer	1.3e-05	0.000136	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.3e-05	0.000409	CbGpPWpGaD
Testosterone Propionate—Urticaria—Prednisone—hematologic cancer	1.3e-05	0.000136	CcSEcCtD
Testosterone Propionate—Headache—Triamcinolone—hematologic cancer	1.3e-05	0.000135	CcSEcCtD
Testosterone Propionate—Abdominal pain—Prednisone—hematologic cancer	1.29e-05	0.000135	CcSEcCtD
Testosterone Propionate—Confusional state—Epirubicin—hematologic cancer	1.29e-05	0.000135	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—MTR—hematologic cancer	1.29e-05	0.000405	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCG2—hematologic cancer	1.29e-05	0.000405	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Betamethasone—hematologic cancer	1.28e-05	0.000134	CcSEcCtD
Testosterone Propionate—Diarrhoea—Dexamethasone—hematologic cancer	1.28e-05	0.000134	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GSTT1—hematologic cancer	1.28e-05	0.000402	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Epirubicin—hematologic cancer	1.28e-05	0.000134	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—hematologic cancer	1.28e-05	0.000134	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ENO2—hematologic cancer	1.26e-05	0.000397	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPS14—hematologic cancer	1.25e-05	0.000394	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—hematologic cancer	1.25e-05	0.000131	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—hematologic cancer	1.25e-05	0.000131	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—SDC1—hematologic cancer	1.25e-05	0.000393	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FHL2—hematologic cancer	1.25e-05	0.000393	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.24e-05	0.00013	CcSEcCtD
Testosterone Propionate—Skin disorder—Epirubicin—hematologic cancer	1.24e-05	0.00013	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.24e-05	0.00039	CbGpPWpGaD
Testosterone Propionate—Dizziness—Dexamethasone—hematologic cancer	1.24e-05	0.00013	CcSEcCtD
Testosterone Propionate—Dizziness—Betamethasone—hematologic cancer	1.24e-05	0.00013	CcSEcCtD
Testosterone Propionate—Insomnia—Methotrexate—hematologic cancer	1.24e-05	0.000129	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—NUP98—hematologic cancer	1.24e-05	0.000388	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Doxorubicin—hematologic cancer	1.23e-05	0.000129	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—hematologic cancer	1.23e-05	0.000129	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—hematologic cancer	1.23e-05	0.000129	CcSEcCtD
Testosterone Propionate—Nausea—Triamcinolone—hematologic cancer	1.23e-05	0.000128	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methotrexate—hematologic cancer	1.23e-05	0.000128	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—AGRN—hematologic cancer	1.23e-05	0.000385	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.23e-05	0.000128	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—hematologic cancer	1.23e-05	0.000385	CbGpPWpGaD
Testosterone Propionate—Discomfort—Doxorubicin—hematologic cancer	1.22e-05	0.000127	CcSEcCtD
Testosterone Propionate—Dyspnoea—Methotrexate—hematologic cancer	1.22e-05	0.000127	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.21e-05	0.000379	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.21e-05	0.000379	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.2e-05	0.000378	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Prednisone—hematologic cancer	1.2e-05	0.000126	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SDC1—hematologic cancer	1.2e-05	0.000376	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—hematologic cancer	1.2e-05	0.000376	CbGpPWpGaD
Testosterone Propionate—Vomiting—Betamethasone—hematologic cancer	1.19e-05	0.000125	CcSEcCtD
Testosterone Propionate—Vomiting—Dexamethasone—hematologic cancer	1.19e-05	0.000125	CcSEcCtD
Testosterone Propionate—Confusional state—Doxorubicin—hematologic cancer	1.19e-05	0.000125	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—NUP214—hematologic cancer	1.19e-05	0.000374	CbGpPWpGaD
Testosterone Propionate—Rash—Betamethasone—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Rash—Dexamethasone—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Dermatitis—Dexamethasone—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Dermatitis—Betamethasone—hematologic cancer	1.18e-05	0.000124	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.18e-05	0.000123	CcSEcCtD
Testosterone Propionate—Fatigue—Methotrexate—hematologic cancer	1.18e-05	0.000123	CcSEcCtD
Testosterone Propionate—Headache—Dexamethasone—hematologic cancer	1.18e-05	0.000123	CcSEcCtD
Testosterone Propionate—Headache—Betamethasone—hematologic cancer	1.18e-05	0.000123	CcSEcCtD
Testosterone Propionate—Asthenia—Prednisone—hematologic cancer	1.17e-05	0.000123	CcSEcCtD
Testosterone Propionate—Pain—Methotrexate—hematologic cancer	1.17e-05	0.000122	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.16e-05	0.000122	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—IDH2—hematologic cancer	1.16e-05	0.000365	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMMR—hematologic cancer	1.16e-05	0.000365	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Doxorubicin—hematologic cancer	1.16e-05	0.000121	CcSEcCtD
Testosterone Propionate—Pruritus—Prednisone—hematologic cancer	1.16e-05	0.000121	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—hematologic cancer	1.16e-05	0.000121	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—hematologic cancer	1.15e-05	0.000362	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—hematologic cancer	1.15e-05	0.00012	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—hematologic cancer	1.15e-05	0.00012	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.14e-05	0.000359	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Epirubicin—hematologic cancer	1.14e-05	0.000119	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.13e-05	0.000355	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Methotrexate—hematologic cancer	1.13e-05	0.000118	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.12e-05	0.000353	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—ABCB1—hematologic cancer	1.12e-05	0.00481	CrCbGaD
Testosterone Propionate—Diarrhoea—Prednisone—hematologic cancer	1.12e-05	0.000117	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.12e-05	0.000117	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.12e-05	0.00035	CbGpPWpGaD
Testosterone Propionate—Nausea—Betamethasone—hematologic cancer	1.11e-05	0.000117	CcSEcCtD
Testosterone Propionate—Nausea—Dexamethasone—hematologic cancer	1.11e-05	0.000117	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.11e-05	0.00035	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.1e-05	0.000115	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—hematologic cancer	1.1e-05	0.000115	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—EIF4EBP1—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPB1—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Testosterone Propionate—Pain—Epirubicin—hematologic cancer	1.09e-05	0.000114	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—ARNTL—hematologic cancer	1.09e-05	0.000343	CbGpPWpGaD
Testosterone Propionate—Urticaria—Methotrexate—hematologic cancer	1.09e-05	0.000113	CcSEcCtD
Testosterone Propionate—Dizziness—Prednisone—hematologic cancer	1.08e-05	0.000113	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.08e-05	0.000339	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Methotrexate—hematologic cancer	1.08e-05	0.000113	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.08e-05	0.000113	CcSEcCtD
Testosterone Propionate—Insomnia—Doxorubicin—hematologic cancer	1.07e-05	0.000112	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.07e-05	0.000335	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CD44—hematologic cancer	1.06e-05	0.000334	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NQO1—hematologic cancer	1.06e-05	0.000334	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ACP5—hematologic cancer	1.06e-05	0.000334	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA9—hematologic cancer	1.06e-05	0.000334	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Doxorubicin—hematologic cancer	1.06e-05	0.000111	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—hematologic cancer	1.05e-05	0.00011	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—hematologic cancer	1.05e-05	0.00011	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—SMC1A—hematologic cancer	1.05e-05	0.00033	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NCOR2—hematologic cancer	1.05e-05	0.00033	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.05e-05	0.000109	CcSEcCtD
Testosterone Propionate—Vomiting—Prednisone—hematologic cancer	1.04e-05	0.000109	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—HRAS—hematologic cancer	1.04e-05	0.000326	CbGpPWpGaD
Testosterone Propionate—Rash—Prednisone—hematologic cancer	1.03e-05	0.000108	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisone—hematologic cancer	1.03e-05	0.000108	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—H3F3A—hematologic cancer	1.03e-05	0.000323	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.02e-05	0.000322	CbGpPWpGaD
Testosterone Propionate—Headache—Prednisone—hematologic cancer	1.02e-05	0.000107	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.02e-05	0.000107	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—hematologic cancer	1.02e-05	0.000107	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NQO1—hematologic cancer	1.02e-05	0.00032	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CD44—hematologic cancer	1.02e-05	0.00032	CbGpPWpGaD
Testosterone Propionate—Urticaria—Epirubicin—hematologic cancer	1.02e-05	0.000106	CcSEcCtD
Testosterone Propionate—Pain—Doxorubicin—hematologic cancer	1.01e-05	0.000106	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—hematologic cancer	1.01e-05	0.000106	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	1.01e-05	0.000317	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.01e-05	0.000317	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Methotrexate—hematologic cancer	1.01e-05	0.000105	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CYCS—hematologic cancer	1.01e-05	0.000316	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—IDH1—hematologic cancer	1e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HSP90AA1—hematologic cancer	1e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.97e-06	0.000313	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.91e-06	0.000311	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TXN—hematologic cancer	9.88e-06	0.000311	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTO1—hematologic cancer	9.88e-06	0.000311	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCC3—hematologic cancer	9.88e-06	0.000311	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—EZH2—hematologic cancer	9.87e-06	0.00031	CbGpPWpGaD
Testosterone Propionate—Asthenia—Methotrexate—hematologic cancer	9.8e-06	0.000102	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Doxorubicin—hematologic cancer	9.75e-06	0.000102	CcSEcCtD
Testosterone Propionate—Nausea—Prednisone—hematologic cancer	9.71e-06	0.000101	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SPHK1—hematologic cancer	9.67e-06	0.000304	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.67e-06	0.000101	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—PARP1—hematologic cancer	9.66e-06	0.000304	CbGpPWpGaD
Testosterone Propionate—Pruritus—Methotrexate—hematologic cancer	9.66e-06	0.000101	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CYCS—hematologic cancer	9.63e-06	0.000303	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HSP90AA1—hematologic cancer	9.57e-06	0.000301	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—hematologic cancer	9.42e-06	9.84e-05	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—hematologic cancer	9.4e-06	9.82e-05	CcSEcCtD
Testosterone Propionate—Abdominal pain—Doxorubicin—hematologic cancer	9.35e-06	9.77e-05	CcSEcCtD
Testosterone Propionate—Diarrhoea—Methotrexate—hematologic cancer	9.35e-06	9.77e-05	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—HDAC2—hematologic cancer	9.32e-06	0.000293	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—hematologic cancer	9.17e-06	9.59e-05	CcSEcCtD
Testosterone Propionate—Progesterone—ABCB1—hematologic cancer	9.12e-06	0.00392	CrCbGaD
Testosterone Propionate—Pruritus—Epirubicin—hematologic cancer	9.04e-06	9.45e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SLC22A1—hematologic cancer	9.04e-06	0.000284	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CRABP1—hematologic cancer	9.04e-06	0.000284	CbGpPWpGaD
Testosterone Propionate—Testosterone—ALB—hematologic cancer	9.04e-06	0.00388	CrCbGaD
Testosterone Propionate—Dizziness—Methotrexate—hematologic cancer	9.03e-06	9.44e-05	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GSTP1—hematologic cancer	8.87e-06	0.000279	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALOX5—hematologic cancer	8.81e-06	0.000277	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—hematologic cancer	8.75e-06	9.14e-05	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Doxorubicin—hematologic cancer	8.72e-06	9.11e-05	CcSEcCtD
Testosterone Propionate—Vomiting—Methotrexate—hematologic cancer	8.69e-06	9.08e-05	CcSEcCtD
Testosterone Propionate—Testosterone—ABCB1—hematologic cancer	8.63e-06	0.0037	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.62e-06	0.000271	CbGpPWpGaD
Testosterone Propionate—Rash—Methotrexate—hematologic cancer	8.61e-06	9e-05	CcSEcCtD
Testosterone Propionate—Dermatitis—Methotrexate—hematologic cancer	8.61e-06	8.99e-05	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—hematologic cancer	8.56e-06	8.94e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—NUP98—hematologic cancer	8.53e-06	0.000268	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—hematologic cancer	8.49e-06	0.000267	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—hematologic cancer	8.49e-06	8.87e-05	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—hematologic cancer	8.45e-06	8.84e-05	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ABCB1—hematologic cancer	8.39e-06	0.000264	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.37e-06	0.000263	CbGpPWpGaD
Testosterone Propionate—Pruritus—Doxorubicin—hematologic cancer	8.37e-06	8.75e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—NCOA3—hematologic cancer	8.28e-06	0.00026	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ADCY7—hematologic cancer	8.28e-06	0.00026	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NUP214—hematologic cancer	8.23e-06	0.000258	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.22e-06	0.000258	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NCOR1—hematologic cancer	8.15e-06	0.000256	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—hematologic cancer	8.15e-06	0.000256	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—hematologic cancer	8.13e-06	8.5e-05	CcSEcCtD
Testosterone Propionate—Nausea—Methotrexate—hematologic cancer	8.11e-06	8.48e-05	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—hematologic cancer	8.09e-06	8.46e-05	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—hematologic cancer	8.06e-06	8.43e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—ABCG2—hematologic cancer	8.06e-06	0.000253	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTR—hematologic cancer	8.06e-06	0.000253	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Epirubicin—hematologic cancer	8.05e-06	8.42e-05	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—hematologic cancer	8.04e-06	0.000253	CbGpPWpGaD
Testosterone Propionate—Headache—Epirubicin—hematologic cancer	8.01e-06	8.37e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—ENO2—hematologic cancer	7.9e-06	0.000248	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—hematologic cancer	7.82e-06	8.18e-05	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—hematologic cancer	7.8e-06	0.000245	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NCOR1—hematologic cancer	7.8e-06	0.000245	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—hematologic cancer	7.66e-06	0.000241	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—hematologic cancer	7.59e-06	7.94e-05	CcSEcCtD
Testosterone Propionate—Vomiting—Doxorubicin—hematologic cancer	7.52e-06	7.86e-05	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SDC1—hematologic cancer	7.49e-06	0.000235	CbGpPWpGaD
Testosterone Propionate—Rash—Doxorubicin—hematologic cancer	7.46e-06	7.8e-05	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—hematologic cancer	7.45e-06	7.79e-05	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—CDKN2B—hematologic cancer	7.45e-06	0.000234	CbGpPWpGaD
Testosterone Propionate—Headache—Doxorubicin—hematologic cancer	7.41e-06	7.75e-05	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—MTHFR—hematologic cancer	7.2e-06	0.000226	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NCOR1—hematologic cancer	7.07e-06	0.000222	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—hematologic cancer	7.03e-06	7.34e-05	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—hematologic cancer	6.9e-06	0.000217	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR3C1—hematologic cancer	6.54e-06	0.000205	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CD44—hematologic cancer	6.37e-06	0.0002	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NQO1—hematologic cancer	6.37e-06	0.0002	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.08e-06	0.000191	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CG—hematologic cancer	6.05e-06	0.00019	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYCS—hematologic cancer	6.03e-06	0.000189	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—hematologic cancer	6e-06	0.000188	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HSP90AA1—hematologic cancer	5.99e-06	0.000188	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CG—hematologic cancer	5.79e-06	0.000182	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MAPK14—hematologic cancer	5.66e-06	0.000178	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CREBBP—hematologic cancer	5.61e-06	0.000176	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—hematologic cancer	5.55e-06	0.000174	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CREBBP—hematologic cancer	5.37e-06	0.000169	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH1—hematologic cancer	5.37e-06	0.000169	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CD—hematologic cancer	5.32e-06	0.000167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—hematologic cancer	5.31e-06	0.000167	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALB—hematologic cancer	5.25e-06	0.000165	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CD—hematologic cancer	5.09e-06	0.00016	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—hematologic cancer	5.03e-06	0.000158	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALB—hematologic cancer	5.03e-06	0.000158	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3R1—hematologic cancer	5.02e-06	0.000158	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NCOR1—hematologic cancer	4.88e-06	0.000153	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—hematologic cancer	4.88e-06	0.000153	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CREBBP—hematologic cancer	4.87e-06	0.000153	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3R1—hematologic cancer	4.81e-06	0.000151	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CB—hematologic cancer	4.64e-06	0.000146	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CB—hematologic cancer	4.44e-06	0.000139	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—hematologic cancer	4.31e-06	0.000136	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—hematologic cancer	4.01e-06	0.000126	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—hematologic cancer	3.84e-06	0.000121	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—EP300—hematologic cancer	3.82e-06	0.00012	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—EP300—hematologic cancer	3.66e-06	0.000115	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CG—hematologic cancer	3.63e-06	0.000114	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CREBBP—hematologic cancer	3.36e-06	0.000106	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CD—hematologic cancer	3.19e-06	0.0001	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALB—hematologic cancer	3.15e-06	9.88e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3R1—hematologic cancer	3.01e-06	9.45e-05	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MAPK3—hematologic cancer	2.97e-06	9.33e-05	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—hematologic cancer	2.89e-06	9.07e-05	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—hematologic cancer	2.83e-06	8.88e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CB—hematologic cancer	2.78e-06	8.73e-05	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—hematologic cancer	2.71e-06	8.5e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—hematologic cancer	2.4e-06	7.54e-05	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—hematologic cancer	2.31e-06	7.25e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EP300—hematologic cancer	2.29e-06	7.19e-05	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—hematologic cancer	2.21e-06	6.95e-05	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—hematologic cancer	2e-06	6.29e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.69e-06	5.32e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—hematologic cancer	1.38e-06	4.35e-05	CbGpPWpGaD
